Rank | Gene Set | Z-score |
---|---|---|
1 | actin-myosin filament sliding (GO:0033275) | 5.74921009 |
2 | muscle filament sliding (GO:0030049) | 5.74921009 |
3 | tricarboxylic acid cycle (GO:0006099) | 5.11015235 |
4 | NADH metabolic process (GO:0006734) | 4.85081363 |
5 | creatine metabolic process (GO:0006600) | 4.62846358 |
6 | actin-mediated cell contraction (GO:0070252) | 4.61770051 |
7 | regulation of actin filament-based movement (GO:1903115) | 4.49872311 |
8 | regulation of relaxation of muscle (GO:1901077) | 4.49605306 |
9 | striated muscle contraction (GO:0006941) | 4.45116143 |
10 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 4.16549733 |
11 | succinate metabolic process (GO:0006105) | 4.12036888 |
12 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 4.05449870 |
13 | glutamate secretion (GO:0014047) | 4.03723664 |
14 | synaptic vesicle exocytosis (GO:0016079) | 4.02486340 |
15 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 3.92205437 |
16 | sodium ion export (GO:0071436) | 3.89456857 |
17 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 3.85730459 |
18 | regulation of acyl-CoA biosynthetic process (GO:0050812) | 3.82358276 |
19 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 3.81355138 |
20 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.77621343 |
21 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 3.71551117 |
22 | regulation of coenzyme metabolic process (GO:0051196) | 3.68696409 |
23 | regulation of cofactor metabolic process (GO:0051193) | 3.68696409 |
24 | vocalization behavior (GO:0071625) | 3.63925687 |
25 | skeletal muscle contraction (GO:0003009) | 3.63045645 |
26 | neurotransmitter-gated ion channel clustering (GO:0072578) | 3.59695384 |
27 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 3.57827604 |
28 | lysine metabolic process (GO:0006553) | 3.55185431 |
29 | lysine catabolic process (GO:0006554) | 3.55185431 |
30 | neurotransmitter secretion (GO:0007269) | 3.51219200 |
31 | synaptic vesicle maturation (GO:0016188) | 3.48974757 |
32 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 3.48012130 |
33 | regulation of synaptic vesicle exocytosis (GO:2000300) | 3.46475143 |
34 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 3.45597538 |
35 | neuronal action potential propagation (GO:0019227) | 3.45055897 |
36 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 3.44062453 |
37 | * oxaloacetate metabolic process (GO:0006107) | 3.43978661 |
38 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 3.40570294 |
39 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 3.38385009 |
40 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 3.36658755 |
41 | regulation of the force of heart contraction (GO:0002026) | 3.33849591 |
42 | gamma-aminobutyric acid transport (GO:0015812) | 3.32275571 |
43 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 3.30504329 |
44 | regulation of glutamate receptor signaling pathway (GO:1900449) | 3.29848088 |
45 | actin filament-based movement (GO:0030048) | 3.28944855 |
46 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 3.26943940 |
47 | glyoxylate metabolic process (GO:0046487) | 3.26904514 |
48 | cellular ketone body metabolic process (GO:0046950) | 3.26098989 |
49 | cell communication by electrical coupling (GO:0010644) | 3.25354778 |
50 | regulation of synaptic vesicle transport (GO:1902803) | 3.21070511 |
51 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 3.19489656 |
52 | neuromuscular process controlling posture (GO:0050884) | 3.18666144 |
53 | actomyosin structure organization (GO:0031032) | 3.18350145 |
54 | cardiac muscle contraction (GO:0060048) | 3.18267453 |
55 | cardiac myofibril assembly (GO:0055003) | 3.14467575 |
56 | response to muscle activity (GO:0014850) | 3.14455828 |
57 | regulation of cardiac muscle cell contraction (GO:0086004) | 3.14063590 |
58 | cell communication involved in cardiac conduction (GO:0086065) | 3.10411110 |
59 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 3.10315519 |
60 | positive regulation of synapse maturation (GO:0090129) | 3.10205558 |
61 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 3.08697595 |
62 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 3.07796631 |
63 | ventricular cardiac muscle cell action potential (GO:0086005) | 3.07486729 |
64 | muscle hypertrophy (GO:0014896) | 3.07020717 |
65 | regulation of skeletal muscle contraction (GO:0014819) | 3.03082333 |
66 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 3.01934937 |
67 | L-phenylalanine catabolic process (GO:0006559) | 3.01052677 |
68 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 3.01052677 |
69 | locomotory exploration behavior (GO:0035641) | 3.00913074 |
70 | cellular sodium ion homeostasis (GO:0006883) | 2.98408337 |
71 | sarcomere organization (GO:0045214) | 2.97509635 |
72 | regulation of cell communication by electrical coupling (GO:0010649) | 2.97434001 |
73 | regulation of synapse structural plasticity (GO:0051823) | 2.97252538 |
74 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 2.97224678 |
75 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 2.96673230 |
76 | L-phenylalanine metabolic process (GO:0006558) | 2.96673230 |
77 | ATP hydrolysis coupled proton transport (GO:0015991) | 2.96287097 |
78 | energy coupled proton transmembrane transport, against electrochemical gradient (GO:0015988) | 2.96287097 |
79 | muscle contraction (GO:0006936) | 2.96246567 |
80 | regulation of membrane repolarization (GO:0060306) | 2.96092194 |
81 | * aspartate family amino acid catabolic process (GO:0009068) | 2.95087635 |
82 | regulation of striated muscle contraction (GO:0006942) | 2.93643240 |
83 | cardiac muscle hypertrophy in response to stress (GO:0014898) | 2.93474829 |
84 | muscle hypertrophy in response to stress (GO:0003299) | 2.93474829 |
85 | cardiac muscle adaptation (GO:0014887) | 2.93474829 |
86 | * gluconeogenesis (GO:0006094) | 2.93454454 |
87 | respiratory electron transport chain (GO:0022904) | 2.92747835 |
88 | oxidative phosphorylation (GO:0006119) | 2.91952053 |
89 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 2.90260920 |
90 | * monosaccharide biosynthetic process (GO:0046364) | 2.89207766 |
91 | regulation of sodium ion transmembrane transporter activity (GO:2000649) | 2.88756305 |
92 | ketone body metabolic process (GO:1902224) | 2.88527512 |
93 | regulation of sulfur metabolic process (GO:0042762) | 2.87639922 |
94 | adult heart development (GO:0007512) | 2.87399757 |
95 | protein localization to synapse (GO:0035418) | 2.85737005 |
96 | behavioral response to cocaine (GO:0048148) | 2.85184624 |
97 | activation of protein kinase A activity (GO:0034199) | 2.84170286 |
98 | electron transport chain (GO:0022900) | 2.84005819 |
99 | cardiac conduction (GO:0061337) | 2.83473946 |
100 | neuron-neuron synaptic transmission (GO:0007270) | 2.81972850 |
101 | negative regulation of calcium ion transmembrane transporter activity (GO:1901020) | 2.81479993 |
102 | negative regulation of calcium ion transmembrane transport (GO:1903170) | 2.81479993 |
103 | cardiac muscle hypertrophy (GO:0003300) | 2.81362094 |
104 | kynurenine metabolic process (GO:0070189) | 2.79845389 |
105 | * 2-oxoglutarate metabolic process (GO:0006103) | 2.79522164 |
106 | ATP synthesis coupled proton transport (GO:0015986) | 2.78657474 |
107 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 2.78657474 |
108 | cardiac muscle cell development (GO:0055013) | 2.78551081 |
109 | carnitine shuttle (GO:0006853) | 2.77646354 |
110 | potassium ion homeostasis (GO:0055075) | 2.77301436 |
111 | detection of calcium ion (GO:0005513) | 2.76588389 |
112 | cardiac muscle tissue morphogenesis (GO:0055008) | 2.76377871 |
113 | striatum development (GO:0021756) | 2.75249821 |
114 | neurotransmitter transport (GO:0006836) | 2.75167277 |
115 | heart process (GO:0003015) | 2.74998067 |
116 | heart contraction (GO:0060047) | 2.74998067 |
117 | response to mercury ion (GO:0046689) | 2.74857380 |
118 | cardiac muscle cell action potential involved in contraction (GO:0086002) | 2.74302625 |
119 | cardiac muscle cell action potential (GO:0086001) | 2.74002384 |
120 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 2.73464802 |
121 | * hexose biosynthetic process (GO:0019319) | 2.73444008 |
122 | glycogen catabolic process (GO:0005980) | 2.71858478 |
123 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 2.69504397 |
124 | regulation of heart rate (GO:0002027) | 2.68551235 |
125 | striated muscle hypertrophy (GO:0014897) | 2.68516674 |
126 | regulation of heart rate by cardiac conduction (GO:0086091) | 2.68158279 |
127 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 2.67761958 |
128 | NAD metabolic process (GO:0019674) | 2.67239429 |
129 | fatty acid transmembrane transport (GO:1902001) | 2.66163856 |
130 | * dicarboxylic acid catabolic process (GO:0043649) | 2.65837664 |
131 | fructose metabolic process (GO:0006000) | 2.65676599 |
132 | relaxation of cardiac muscle (GO:0055119) | 2.64597179 |
133 | muscle system process (GO:0003012) | 2.64487394 |
134 | myofibril assembly (GO:0030239) | 2.64452768 |
135 | * glutamate metabolic process (GO:0006536) | 2.64236029 |
136 | membrane depolarization during action potential (GO:0086010) | 2.64171870 |
137 | positive regulation of sodium ion transport (GO:0010765) | 2.63689417 |
138 | regulation of neurotransmitter levels (GO:0001505) | 2.63574997 |
139 | regulation of voltage-gated calcium channel activity (GO:1901385) | 2.63489156 |
140 | regulation of sodium ion transmembrane transport (GO:1902305) | 2.63212228 |
141 | glycolytic process (GO:0006096) | 2.62699459 |
142 | regulation of calcium ion transmembrane transporter activity (GO:1901019) | 2.61807655 |
143 | regulation of calcium ion transmembrane transport (GO:1903169) | 2.61807655 |
144 | cellular potassium ion homeostasis (GO:0030007) | 2.61651461 |
145 | epoxygenase P450 pathway (GO:0019373) | 2.59405167 |
146 | muscle tissue morphogenesis (GO:0060415) | 2.58624593 |
Rank | Gene Set | Z-score |
---|---|---|
1 | EZH2_22144423_ChIP-Seq_EOC_Human | 4.45987741 |
2 | * ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 3.92700722 |
3 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 3.72729207 |
4 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.34866377 |
5 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 3.17671998 |
6 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.57012652 |
7 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.52667476 |
8 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.52485064 |
9 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.47905022 |
10 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.43217851 |
11 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.41525223 |
12 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.41417656 |
13 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.35207631 |
14 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 2.24996389 |
15 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 2.20106262 |
16 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.10329000 |
17 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.09937565 |
18 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.08678170 |
19 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.02984205 |
20 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.02690069 |
21 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.94189406 |
22 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.92682293 |
23 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.91282279 |
24 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.87571327 |
25 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.87571327 |
26 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.80281106 |
27 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.79730995 |
28 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.76809615 |
29 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.76270756 |
30 | * EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.70876032 |
31 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.64120745 |
32 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.63484923 |
33 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.63378904 |
34 | * TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.61553860 |
35 | * TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.61553860 |
36 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 1.57801920 |
37 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.57380587 |
38 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 1.55430901 |
39 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.54714121 |
40 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.54666710 |
41 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.53423394 |
42 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.53152847 |
43 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.51346278 |
44 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.51316939 |
45 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.51175124 |
46 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.50230945 |
47 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.49857186 |
48 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.47686407 |
49 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.46165432 |
50 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.43723936 |
51 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.40283569 |
52 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.40217806 |
53 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.37212572 |
54 | * PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.34039440 |
55 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.33753507 |
56 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.31858880 |
57 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.30990424 |
58 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.28886954 |
59 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.27642896 |
60 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.27257203 |
61 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 1.24864555 |
62 | * RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.23890701 |
63 | * GATA4_21415370_ChIP-Seq_HL-1_Mouse | 1.23356433 |
64 | * RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 1.23337602 |
65 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.23012141 |
66 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.22321268 |
67 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.22140568 |
68 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.21885057 |
69 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.21077426 |
70 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 1.20781017 |
71 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.20271834 |
72 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.18688439 |
73 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.18387202 |
74 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.15887676 |
75 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.14155867 |
76 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.12165373 |
77 | VDR_22108803_ChIP-Seq_LS180_Human | 1.10634758 |
78 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.10091462 |
79 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.09969550 |
80 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.08808424 |
81 | P300_19829295_ChIP-Seq_ESCs_Human | 1.07563866 |
82 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 1.07102298 |
83 | AR_25329375_ChIP-Seq_VCAP_Human | 1.06788184 |
84 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.05827995 |
85 | * NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.05772926 |
86 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.04826042 |
87 | AR_19668381_ChIP-Seq_PC3_Human | 1.04503053 |
88 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.03969648 |
89 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.03803879 |
90 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 1.02514972 |
91 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 1.02492521 |
92 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.01386645 |
93 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.01277369 |
94 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.00408547 |
95 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.00207093 |
96 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.99027995 |
97 | ZNF274_21170338_ChIP-Seq_K562_Hela | 0.98480772 |
98 | TBX5_21415370_ChIP-Seq_HL-1_Mouse | 0.98312497 |
99 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 0.97155441 |
100 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.96788914 |
101 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.96112582 |
102 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 0.95665330 |
103 | * SMAD3_21741376_ChIP-Seq_EPCs_Human | 0.95476974 |
104 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.94513443 |
105 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 0.94124992 |
106 | STAT3_23295773_ChIP-Seq_U87_Human | 0.93821513 |
107 | * TET1_21451524_ChIP-Seq_MESCs_Mouse | 0.93733733 |
108 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 0.93692707 |
109 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.92797589 |
110 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 0.92438888 |
111 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 0.92256161 |
112 | * CTCF_27219007_Chip-Seq_Bcells_Human | 0.92184924 |
113 | * EGR1_23403033_ChIP-Seq_LIVER_Mouse | 0.91999442 |
114 | TRIM28_19339689_ChIP-ChIP_MESCs_Mouse | 0.91868753 |
115 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.91516522 |
116 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 0.91217886 |
117 | * SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.90989891 |
118 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 0.90942672 |
119 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.90425424 |
120 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 0.89600860 |
121 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.88943652 |
122 | * SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.88321430 |
123 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.88154729 |
124 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.88148293 |
125 | * CREB1_15753290_ChIP-ChIP_HEK293T_Human | 0.87602852 |
126 | TCF4_23295773_ChIP-Seq_U87_Human | 0.87502231 |
127 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.87494054 |
128 | SETDB1_19884255_ChIP-Seq_MESCs_Mouse | 0.85949133 |
129 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.83710336 |
130 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.83557887 |
131 | NACC1_18358816_ChIP-ChIP_MESCs_Mouse | 0.83169378 |
132 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 0.82874919 |
133 | * CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 0.82305831 |
134 | * SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.82224735 |
135 | OCT4_18692474_ChIP-Seq_MEFs_Mouse | 0.82138721 |
136 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.82093944 |
137 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.81770803 |
138 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 0.81702730 |
139 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 0.79278811 |
140 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 0.79119016 |
141 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.77983080 |
142 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 0.77966884 |
143 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.77791144 |
144 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.77488380 |
145 | * CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 0.76394896 |
146 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 0.74317492 |
147 | KLF4_19829295_ChIP-Seq_ESCs_Human | 0.74276558 |
148 | * SMAD4_21741376_ChIP-Seq_EPCs_Human | 0.74274795 |
149 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 0.73088704 |
150 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.72999084 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0002837_dystrophic_cardiac_calcinosis | 4.28163888 |
2 | MP0004859_abnormal_synaptic_plasticity | 3.96595105 |
3 | MP0003646_muscle_fatigue | 3.65325888 |
4 | MP0003880_abnormal_central_pattern | 3.43908405 |
5 | MP0000751_myopathy | 3.21423525 |
6 | MP0003635_abnormal_synaptic_transmissio | 2.75517568 |
7 | MP0002822_catalepsy | 2.74903654 |
8 | MP0004215_abnormal_myocardial_fiber | 2.67454995 |
9 | MP0004084_abnormal_cardiac_muscle | 2.66864061 |
10 | MP0009046_muscle_twitch | 2.65833806 |
11 | MP0002139_abnormal_hepatobiliary_system | 2.50549397 |
12 | MP0005085_abnormal_gallbladder_physiolo | 2.49363489 |
13 | MP0009745_abnormal_behavioral_response | 2.48341816 |
14 | MP0005360_urolithiasis | 2.45923707 |
15 | MP0002064_seizures | 2.44028897 |
16 | MP0004036_abnormal_muscle_relaxation | 2.42608012 |
17 | MP0002063_abnormal_learning/memory/cond | 2.18981145 |
18 | MP0004270_analgesia | 2.18310593 |
19 | MP0008875_abnormal_xenobiotic_pharmacok | 2.08289252 |
20 | MP0000749_muscle_degeneration | 2.01714074 |
21 | MP0001968_abnormal_touch/_nociception | 2.01494500 |
22 | MP0002272_abnormal_nervous_system | 1.94446784 |
23 | MP0005365_abnormal_bile_salt | 1.94066014 |
24 | MP0002572_abnormal_emotion/affect_behav | 1.87955473 |
25 | MP0005330_cardiomyopathy | 1.84811400 |
26 | MP0004130_abnormal_muscle_cell | 1.83593888 |
27 | MP0002736_abnormal_nociception_after | 1.77728018 |
28 | MP0006036_abnormal_mitochondrial_physio | 1.69952920 |
29 | MP0003806_abnormal_nucleotide_metabolis | 1.69898565 |
30 | MP0005451_abnormal_body_composition | 1.68208825 |
31 | MP0003137_abnormal_impulse_conducting | 1.61711663 |
32 | MP0001440_abnormal_grooming_behavior | 1.56924201 |
33 | MP0004145_abnormal_muscle_electrophysio | 1.56471026 |
34 | MP0001501_abnormal_sleep_pattern | 1.55935449 |
35 | MP0004484_altered_response_of | 1.55385624 |
36 | MP0001486_abnormal_startle_reflex | 1.53591792 |
37 | MP0004085_abnormal_heartbeat | 1.53260384 |
38 | MP0002972_abnormal_cardiac_muscle | 1.53154326 |
39 | MP0006035_abnormal_mitochondrial_morpho | 1.52829487 |
40 | MP0005620_abnormal_muscle_contractility | 1.52387733 |
41 | MP0005670_abnormal_white_adipose | 1.49077448 |
42 | MP0002269_muscular_atrophy | 1.48867034 |
43 | MP0002734_abnormal_mechanical_nocicepti | 1.47650858 |
44 | MP0003195_calcinosis | 1.46079505 |
45 | MP0003329_amyloid_beta_deposits | 1.45980041 |
46 | MP0009780_abnormal_chondrocyte_physiolo | 1.42351234 |
47 | MP0004233_abnormal_muscle_weight | 1.42094990 |
48 | MP0010329_abnormal_lipoprotein_level | 1.41532862 |
49 | MP0002067_abnormal_sensory_capabilities | 1.40319906 |
50 | MP0004087_abnormal_muscle_fiber | 1.39787420 |
51 | MP0002909_abnormal_adrenal_gland | 1.39374596 |
52 | MP0004924_abnormal_behavior | 1.38869515 |
53 | MP0005386_behavior/neurological_phenoty | 1.38869515 |
54 | MP0002735_abnormal_chemical_nociception | 1.38644167 |
55 | MP0008775_abnormal_heart_ventricle | 1.36506653 |
56 | MP0002332_abnormal_exercise_endurance | 1.36157453 |
57 | MP0005332_abnormal_amino_acid | 1.34605503 |
58 | MP0003123_paternal_imprinting | 1.32013377 |
59 | MP0003879_abnormal_hair_cell | 1.29501648 |
60 | MP0004147_increased_porphyrin_level | 1.29374884 |
61 | MP0000747_muscle_weakness | 1.29116150 |
62 | MP0005646_abnormal_pituitary_gland | 1.26228656 |
63 | MP0004142_abnormal_muscle_tone | 1.24647078 |
64 | MP0006138_congestive_heart_failure | 1.23173344 |
65 | MP0001984_abnormal_olfaction | 1.20636734 |
66 | MP0008569_lethality_at_weaning | 1.17159426 |
67 | MP0002106_abnormal_muscle_physiology | 1.16821017 |
68 | MP0005385_cardiovascular_system_phenoty | 1.15616639 |
69 | MP0001544_abnormal_cardiovascular_syste | 1.15616639 |
70 | MP0001529_abnormal_vocalization | 1.14035162 |
71 | MP0005423_abnormal_somatic_nervous | 1.10474050 |
72 | MP0001970_abnormal_pain_threshold | 1.09778067 |
73 | MP0004043_abnormal_pH_regulation | 1.09649820 |
74 | MP0005535_abnormal_body_temperature | 1.08462616 |
75 | MP0003252_abnormal_bile_duct | 1.07259446 |
76 | MP0009840_abnormal_foam_cell | 1.06834257 |
77 | MP0006276_abnormal_autonomic_nervous | 1.05988670 |
78 | MP0002733_abnormal_thermal_nociception | 1.04237812 |
79 | MP0005083_abnormal_biliary_tract | 1.04139665 |
80 | MP0008874_decreased_physiological_sensi | 1.01088062 |
81 | MP0002066_abnormal_motor_capabilities/c | 0.99333608 |
82 | MP0003633_abnormal_nervous_system | 0.98944915 |
83 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.97280432 |
84 | MP0005369_muscle_phenotype | 0.96700187 |
85 | MP0004510_myositis | 0.96600169 |
86 | MP0005266_abnormal_metabolism | 0.96056493 |
87 | MP0008872_abnormal_physiological_respon | 0.96006106 |
88 | MP0005551_abnormal_eye_electrophysiolog | 0.95731579 |
89 | MP0000759_abnormal_skeletal_muscle | 0.95386909 |
90 | MP0004811_abnormal_neuron_physiology | 0.93781578 |
91 | MP0002876_abnormal_thyroid_physiology | 0.93091451 |
92 | MP0009697_abnormal_copulation | 0.91647221 |
93 | MP0002118_abnormal_lipid_homeostasis | 0.91476294 |
94 | MP0000013_abnormal_adipose_tissue | 0.89779903 |
95 | MP0001661_extended_life_span | 0.89336690 |
96 | MP0000604_amyloidosis | 0.88151815 |
97 | MP0005165_increased_susceptibility_to | 0.87828591 |
98 | MP0002557_abnormal_social/conspecific_i | 0.86844512 |
99 | MP0000750_abnormal_muscle_regeneration | 0.85063081 |
100 | MP0002229_neurodegeneration | 0.81228271 |
101 | MP0005187_abnormal_penis_morphology | 0.80493203 |
102 | MP0003868_abnormal_feces_composition | 0.80466368 |
103 | MP0003221_abnormal_cardiomyocyte_apopto | 0.80305384 |
104 | MP0003631_nervous_system_phenotype | 0.79389278 |
105 | MP0005319_abnormal_enzyme/_coenzyme | 0.78703892 |
106 | MP0002090_abnormal_vision | 0.77479734 |
107 | MP0010630_abnormal_cardiac_muscle | 0.77165566 |
108 | MP0002184_abnormal_innervation | 0.77145750 |
109 | MP0000230_abnormal_systemic_arterial | 0.76448063 |
110 | MP0002127_abnormal_cardiovascular_syste | 0.75443163 |
111 | MP0001346_abnormal_lacrimal_gland | 0.73680531 |
112 | MP0001666_abnormal_nutrient_absorption | 0.69136728 |
113 | MP0000003_abnormal_adipose_tissue | 0.68929047 |
114 | MP0002234_abnormal_pharynx_morphology | 0.66174268 |
115 | MP0002971_abnormal_brown_adipose | 0.66096667 |
116 | MP0000920_abnormal_myelination | 0.64428800 |
117 | MP0001502_abnormal_circadian_rhythm | 0.63037477 |
118 | MP0001299_abnormal_eye_distance/ | 0.58807574 |
119 | MP0009672_abnormal_birth_weight | 0.56317030 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Muscle fiber inclusion bodies (HP:0100299) | 6.10017453 |
2 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 5.94398242 |
3 | Nemaline bodies (HP:0003798) | 5.92290305 |
4 | Focal motor seizures (HP:0011153) | 5.38350052 |
5 | Type 1 muscle fiber predominance (HP:0003803) | 4.48494454 |
6 | Sudden death (HP:0001699) | 4.16501728 |
7 | Exercise-induced myalgia (HP:0003738) | 4.06594270 |
8 | Myokymia (HP:0002411) | 3.95264680 |
9 | Exercise-induced muscle cramps (HP:0003710) | 3.68760349 |
10 | Atonic seizures (HP:0010819) | 3.60948512 |
11 | Focal seizures (HP:0007359) | 3.46716655 |
12 | Abnormality of the left ventricular outflow tract (HP:0011103) | 3.39995307 |
13 | Subaortic stenosis (HP:0001682) | 3.39995307 |
14 | Abnormal mitochondria in muscle tissue (HP:0008316) | 3.39092974 |
15 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 3.36061358 |
16 | Pheochromocytoma (HP:0002666) | 3.34291787 |
17 | Distal lower limb muscle weakness (HP:0009053) | 3.33085731 |
18 | Calf muscle hypertrophy (HP:0008981) | 3.28091278 |
19 | Myoglobinuria (HP:0002913) | 3.26437403 |
20 | Myopathic facies (HP:0002058) | 3.24508723 |
21 | Acute necrotizing encephalopathy (HP:0006965) | 3.21187565 |
22 | Absence seizures (HP:0002121) | 3.18767034 |
23 | Epileptic encephalopathy (HP:0200134) | 3.18317352 |
24 | Febrile seizures (HP:0002373) | 3.16449864 |
25 | Muscle hypertrophy of the lower extremities (HP:0008968) | 3.11236679 |
26 | Hyperventilation (HP:0002883) | 3.11178356 |
27 | Rimmed vacuoles (HP:0003805) | 3.08676859 |
28 | Neck muscle weakness (HP:0000467) | 3.07518494 |
29 | Acute encephalopathy (HP:0006846) | 3.07380850 |
30 | Dysmetric saccades (HP:0000641) | 3.06995885 |
31 | Cerebral edema (HP:0002181) | 3.06670257 |
32 | Neuroendocrine neoplasm (HP:0100634) | 3.06408982 |
33 | Visual hallucinations (HP:0002367) | 3.04786211 |
34 | Syncope (HP:0001279) | 2.99147287 |
35 | EMG: neuropathic changes (HP:0003445) | 2.95972938 |
36 | Atrial fibrillation (HP:0005110) | 2.92109044 |
37 | Dilated cardiomyopathy (HP:0001644) | 2.90531080 |
38 | Generalized tonic-clonic seizures (HP:0002069) | 2.90175380 |
39 | Bundle branch block (HP:0011710) | 2.90143432 |
40 | Palpitations (HP:0001962) | 2.86492893 |
41 | Dialeptic seizures (HP:0011146) | 2.85040370 |
42 | Abnormality of glycolysis (HP:0004366) | 2.82849100 |
43 | Increased serum pyruvate (HP:0003542) | 2.82849100 |
44 | Abnormality of the calf musculature (HP:0001430) | 2.79222305 |
45 | Hepatocellular necrosis (HP:0001404) | 2.76493530 |
46 | Primary atrial arrhythmia (HP:0001692) | 2.76084413 |
47 | Progressive macrocephaly (HP:0004481) | 2.76062199 |
48 | Asymmetric septal hypertrophy (HP:0001670) | 2.71970499 |
49 | Ventricular fibrillation (HP:0001663) | 2.71856044 |
50 | Hepatic necrosis (HP:0002605) | 2.70633259 |
51 | Cholecystitis (HP:0001082) | 2.70504202 |
52 | Abnormal gallbladder physiology (HP:0012438) | 2.70504202 |
53 | Ketoacidosis (HP:0001993) | 2.66899921 |
54 | Ketosis (HP:0001946) | 2.66768012 |
55 | Ventricular tachycardia (HP:0004756) | 2.64442340 |
56 | Supraventricular tachycardia (HP:0004755) | 2.64361968 |
57 | Distal arthrogryposis (HP:0005684) | 2.63688489 |
58 | Increased connective tissue (HP:0009025) | 2.62950429 |
59 | Hyperammonemia (HP:0001987) | 2.60618232 |
60 | Mitochondrial inheritance (HP:0001427) | 2.60227008 |
61 | Muscle stiffness (HP:0003552) | 2.59444095 |
62 | Cholelithiasis (HP:0001081) | 2.59375092 |
63 | Increased CSF lactate (HP:0002490) | 2.56687186 |
64 | Supraventricular arrhythmia (HP:0005115) | 2.55361208 |
65 | Status epilepticus (HP:0002133) | 2.53387746 |
66 | Ragged-red muscle fibers (HP:0003200) | 2.48214576 |
67 | Abnormality of the foot musculature (HP:0001436) | 2.45316353 |
68 | Impaired social interactions (HP:0000735) | 2.45118514 |
69 | Abnormal social behavior (HP:0012433) | 2.45118514 |
70 | Prolonged partial thromboplastin time (HP:0003645) | 2.44814045 |
71 | Heart block (HP:0012722) | 2.42188068 |
72 | Gout (HP:0001997) | 2.41489863 |
73 | Dysdiadochokinesis (HP:0002075) | 2.41214564 |
74 | Myotonia (HP:0002486) | 2.40022818 |
75 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.39546556 |
76 | Abnormal gallbladder morphology (HP:0012437) | 2.38960357 |
77 | Poor eye contact (HP:0000817) | 2.37921475 |
78 | Ventricular arrhythmia (HP:0004308) | 2.36756058 |
79 | Abnormality of the lower motor neuron (HP:0002366) | 2.36244810 |
80 | Areflexia of lower limbs (HP:0002522) | 2.35556495 |
81 | Lactic acidosis (HP:0003128) | 2.35447228 |
82 | Difficulty running (HP:0009046) | 2.33963418 |
83 | Prolonged QT interval (HP:0001657) | 2.33922833 |
84 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.33273592 |
85 | EMG: myopathic abnormalities (HP:0003458) | 2.31893502 |
86 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.31628952 |
87 | Deep venous thrombosis (HP:0002625) | 2.31401016 |
88 | Increased intramyocellular lipid droplets (HP:0012240) | 2.30215564 |
89 | Atrioventricular block (HP:0001678) | 2.29424728 |
90 | Foot dorsiflexor weakness (HP:0009027) | 2.29416747 |
91 | Hyporeflexia of lower limbs (HP:0002600) | 2.25879068 |
92 | Rhabdomyolysis (HP:0003201) | 2.24569297 |
93 | Hypobetalipoproteinemia (HP:0003563) | 2.24262939 |
94 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.23823578 |
95 | Progressive cerebellar ataxia (HP:0002073) | 2.23273816 |
96 | Round ear (HP:0100830) | 2.22222964 |
97 | Progressive muscle weakness (HP:0003323) | 2.21154935 |
98 | Distal lower limb amyotrophy (HP:0008944) | 2.21094735 |
99 | Exercise intolerance (HP:0003546) | 2.20817043 |
100 | Abnormal atrioventricular conduction (HP:0005150) | 2.20299040 |
101 | Right ventricular cardiomyopathy (HP:0011663) | 2.20134850 |
102 | Anxiety (HP:0000739) | 2.19898266 |
103 | Muscle fiber splitting (HP:0003555) | 2.18093336 |
104 | Resting tremor (HP:0002322) | 2.17041999 |
105 | Lethargy (HP:0001254) | 2.16179320 |
106 | Lower limb amyotrophy (HP:0007210) | 2.16136875 |
107 | Hyperglycinemia (HP:0002154) | 2.15544993 |
108 | Xanthomatosis (HP:0000991) | 2.14229406 |
109 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.14155400 |
110 | Abnormality of alanine metabolism (HP:0010916) | 2.14155400 |
111 | Hyperalaninemia (HP:0003348) | 2.14155400 |
112 | Hyperlipoproteinemia (HP:0010980) | 2.12990967 |
113 | Frequent falls (HP:0002359) | 2.11692677 |
114 | Central scotoma (HP:0000603) | 2.11522559 |
115 | Oligomenorrhea (HP:0000876) | 2.10550648 |
116 | Increased variability in muscle fiber diameter (HP:0003557) | 2.09911965 |
117 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.09252024 |
118 | Intrahepatic cholestasis (HP:0001406) | 2.08566109 |
119 | Athetosis (HP:0002305) | 2.07657731 |
120 | Hyperglycinuria (HP:0003108) | 2.07500513 |
121 | Left ventricular hypertrophy (HP:0001712) | 2.07484596 |
122 | Hypoalphalipoproteinemia (HP:0003233) | 2.06054618 |
123 | Depression (HP:0000716) | 2.06004658 |
124 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.05044645 |
125 | Increased muscle lipid content (HP:0009058) | 2.02565626 |
126 | Metabolic acidosis (HP:0001942) | 2.02174717 |
127 | Abnormal EKG (HP:0003115) | 2.01312289 |
128 | Hypolipoproteinemia (HP:0010981) | 2.00994423 |
129 | Abnormality of glycine metabolism (HP:0010895) | 1.99103139 |
130 | Abnormality of serine family amino acid metabolism (HP:0010894) | 1.99103139 |
131 | Broad-based gait (HP:0002136) | 1.95583408 |
132 | Cerebral hypomyelination (HP:0006808) | 1.95036096 |
133 | Lipoatrophy (HP:0100578) | 1.94361246 |
134 | Postural instability (HP:0002172) | 1.93811636 |
135 | Respiratory failure (HP:0002878) | 1.92890203 |
136 | Complement deficiency (HP:0004431) | 1.92725372 |
137 | Generalized muscle weakness (HP:0003324) | 1.89715857 |
138 | Calcaneovalgus deformity (HP:0001848) | 1.85509974 |
139 | Ankle clonus (HP:0011448) | 1.83394610 |
140 | Ulnar deviation of the wrist (HP:0003049) | 1.76623028 |
141 | Tetraplegia (HP:0002445) | 1.74434816 |
142 | Difficulty climbing stairs (HP:0003551) | 1.74124496 |
143 | Limb-girdle muscle atrophy (HP:0003797) | 1.72214231 |
144 | Action tremor (HP:0002345) | 1.70885280 |
145 | Decreased number of large peripheral myelinated nerve fibers (HP:0003387) | 1.70606789 |
146 | Fetal akinesia sequence (HP:0001989) | 1.68008086 |
Rank | Gene Set | Z-score |
---|---|---|
1 | EPHA4 | 3.40332634 |
2 | NTRK3 | 3.12540171 |
3 | MAP3K4 | 3.10293985 |
4 | PDK3 | 2.99210735 |
5 | PDK4 | 2.99210735 |
6 | NEK1 | 2.91877609 |
7 | MAP2K4 | 2.63090182 |
8 | MAP3K12 | 2.56930641 |
9 | MAP3K9 | 2.47881903 |
10 | MAP2K7 | 2.39150323 |
11 | DAPK2 | 2.36226821 |
12 | CASK | 2.33919058 |
13 | PHKG1 | 2.27263557 |
14 | PHKG2 | 2.27263557 |
15 | PINK1 | 1.96834460 |
16 | TTN | 1.90902877 |
17 | MINK1 | 1.89911650 |
18 | OBSCN | 1.87056039 |
19 | BCKDK | 1.85778622 |
20 | LMTK2 | 1.85327782 |
21 | PDK2 | 1.84638240 |
22 | DAPK1 | 1.75940378 |
23 | MYLK | 1.65246326 |
24 | LIMK1 | 1.62088529 |
25 | CDK19 | 1.51254168 |
26 | STK38 | 1.47960539 |
27 | PAK6 | 1.47160181 |
28 | PLK2 | 1.46926365 |
29 | KSR2 | 1.40502131 |
30 | AKT3 | 1.32995935 |
31 | CAMKK1 | 1.29755141 |
32 | ARAF | 1.27347699 |
33 | GRK5 | 1.23054946 |
34 | TSSK6 | 1.22886413 |
35 | NME1 | 1.21678465 |
36 | CCNB1 | 1.18888279 |
37 | PRKCG | 1.15118700 |
38 | CAMK2A | 1.12650695 |
39 | PRPF4B | 1.09142821 |
40 | EIF2AK1 | 1.08940283 |
41 | PKN2 | 1.06508334 |
42 | MARK1 | 1.05118952 |
43 | PBK | 1.04505382 |
44 | SGK2 | 1.04501981 |
45 | SGK223 | 1.01102514 |
46 | SGK494 | 1.01102514 |
47 | NTRK2 | 1.00544259 |
48 | BRSK1 | 0.99872757 |
49 | AKT2 | 0.95507143 |
50 | RIPK1 | 0.95447395 |
51 | SGK3 | 0.95273006 |
52 | CDK5 | 0.95062147 |
53 | BUB1 | 0.94632201 |
54 | CAMK2D | 0.94270063 |
55 | OXSR1 | 0.92656208 |
56 | PAK3 | 0.92336491 |
57 | KSR1 | 0.92214239 |
58 | DAPK3 | 0.91061588 |
59 | EEF2K | 0.87541207 |
60 | SCYL2 | 0.86442521 |
61 | CAMK2G | 0.86342717 |
62 | PRKD3 | 0.86281295 |
63 | GRK7 | 0.83091750 |
64 | MAPKAPK3 | 0.82521304 |
65 | MAP3K7 | 0.82286160 |
66 | MAPK12 | 0.81756303 |
67 | RIPK4 | 0.80721059 |
68 | CAMKK2 | 0.78577562 |
69 | TESK1 | 0.78006615 |
70 | PTK2B | 0.76660858 |
71 | CDK11A | 0.75478271 |
72 | LATS2 | 0.74614984 |
73 | CAMK2B | 0.74545257 |
74 | PDPK1 | 0.74203934 |
75 | PDK1 | 0.73538911 |
76 | CAMK1 | 0.71435060 |
77 | ICK | 0.71248947 |
78 | CAMK4 | 0.70700562 |
79 | MST1R | 0.70109534 |
80 | NTRK1 | 0.69103705 |
81 | ERBB4 | 0.64561240 |
82 | MUSK | 0.63609909 |
83 | TTK | 0.63414667 |
84 | PRKCH | 0.61408075 |
85 | PNCK | 0.61126822 |
86 | RAF1 | 0.59140354 |
87 | SGK1 | 0.56764207 |
88 | ROCK2 | 0.56369788 |
89 | PRKCE | 0.55793959 |
90 | TRIB3 | 0.55343537 |
91 | TAOK1 | 0.55110336 |
92 | DMPK | 0.54573227 |
93 | ALK | 0.54396581 |
94 | STK11 | 0.53891345 |
95 | MAP3K5 | 0.53733229 |
96 | FER | 0.53519536 |
97 | MAP3K13 | 0.52752181 |
98 | CDK18 | 0.52641533 |
99 | RET | 0.52526726 |
100 | CDC42BPA | 0.51662423 |
101 | MAPK10 | 0.50555183 |
102 | PKN1 | 0.50417938 |
103 | PIK3CA | 0.49980342 |
104 | BRAF | 0.49684080 |
105 | PIK3CG | 0.49401044 |
106 | CDK15 | 0.49182557 |
107 | PRKAA2 | 0.48381808 |
108 | STK38L | 0.48217542 |
109 | RPS6KA3 | 0.47784944 |
110 | MAP3K1 | 0.47715835 |
111 | PRKAA1 | 0.47333351 |
112 | PRKACA | 0.46399726 |
113 | CDK14 | 0.45631674 |
114 | PRKACG | 0.45541602 |
115 | FES | 0.43958202 |
116 | INSRR | 0.43250187 |
117 | MAP2K1 | 0.42177942 |
118 | MAPK7 | 0.41407488 |
119 | MAP2K6 | 0.40716507 |
120 | CSNK1E | 0.40469961 |
121 | TRPM7 | 0.40059955 |
122 | MAPK13 | 0.37659790 |
123 | PRKACB | 0.37566286 |
124 | UHMK1 | 0.37518999 |
125 | ROCK1 | 0.36848613 |
126 | PRKG1 | 0.36787940 |
127 | PRKD1 | 0.36650848 |
128 | ERBB3 | 0.36572830 |
129 | STK16 | 0.35380049 |
130 | MAPKAPK5 | 0.35303721 |
131 | DYRK1A | 0.35262557 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 3.96901756 |
2 | * 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.97850071 |
3 | * Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.97798910 |
4 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 2.59568642 |
5 | Nicotine addiction_Homo sapiens_hsa05033 | 2.31667063 |
6 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.31161654 |
7 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.30276591 |
8 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.13676160 |
9 | Pyruvate metabolism_Homo sapiens_hsa00620 | 2.07964224 |
10 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.07154389 |
11 | * Arginine biosynthesis_Homo sapiens_hsa00220 | 2.00707974 |
12 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.96646779 |
13 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.89934241 |
14 | * Carbon metabolism_Homo sapiens_hsa01200 | 1.88290397 |
15 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.87062001 |
16 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.85436641 |
17 | Parkinsons disease_Homo sapiens_hsa05012 | 1.76855878 |
18 | GABAergic synapse_Homo sapiens_hsa04727 | 1.76546339 |
19 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.74338089 |
20 | * Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.69995175 |
21 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.61387225 |
22 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.59980756 |
23 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.59957327 |
24 | Olfactory transduction_Homo sapiens_hsa04740 | 1.57884420 |
25 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.55679966 |
26 | * Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.48289135 |
27 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.44298225 |
28 | Circadian entrainment_Homo sapiens_hsa04713 | 1.44038089 |
29 | Morphine addiction_Homo sapiens_hsa05032 | 1.37651439 |
30 | Alzheimers disease_Homo sapiens_hsa05010 | 1.37212942 |
31 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.34105300 |
32 | Long-term potentiation_Homo sapiens_hsa04720 | 1.27870863 |
33 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.23898511 |
34 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.22456210 |
35 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.21931540 |
36 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.19088674 |
37 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.18507438 |
38 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.18072098 |
39 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.16329643 |
40 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.15302630 |
41 | Insulin secretion_Homo sapiens_hsa04911 | 1.12482991 |
42 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.12145301 |
43 | Bile secretion_Homo sapiens_hsa04976 | 1.07792911 |
44 | * Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.05595016 |
45 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.03624480 |
46 | Salivary secretion_Homo sapiens_hsa04970 | 1.03477730 |
47 | Huntingtons disease_Homo sapiens_hsa05016 | 0.99689044 |
48 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.98185932 |
49 | Taste transduction_Homo sapiens_hsa04742 | 0.96365428 |
50 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.95204870 |
51 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.93946919 |
52 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.93389870 |
53 | Histidine metabolism_Homo sapiens_hsa00340 | 0.92904968 |
54 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.91206205 |
55 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.90665092 |
56 | Peroxisome_Homo sapiens_hsa04146 | 0.90147063 |
57 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.87634100 |
58 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.87584023 |
59 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.87091483 |
60 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.86716352 |
61 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.86324357 |
62 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.85926620 |
63 | Renin secretion_Homo sapiens_hsa04924 | 0.85743352 |
64 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.85254354 |
65 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.84421708 |
66 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.84399708 |
67 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.82697237 |
68 | Prion diseases_Homo sapiens_hsa05020 | 0.81572669 |
69 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.79447854 |
70 | Retinol metabolism_Homo sapiens_hsa00830 | 0.78366344 |
71 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.75919598 |
72 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.74421850 |
73 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.73746242 |
74 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.72736681 |
75 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.71466667 |
76 | Sulfur relay system_Homo sapiens_hsa04122 | 0.66143922 |
77 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.65588865 |
78 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.63157396 |
79 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.60654761 |
80 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.60591716 |
81 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.60030800 |
82 | Phototransduction_Homo sapiens_hsa04744 | 0.59645124 |
83 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.59386931 |
84 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.59180230 |
85 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.58150427 |
86 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.55254416 |
87 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.54892435 |
88 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.54073477 |
89 | Cocaine addiction_Homo sapiens_hsa05030 | 0.52462535 |
90 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.52338622 |
91 | Long-term depression_Homo sapiens_hsa04730 | 0.51525604 |
92 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.48939830 |
93 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.48253853 |
94 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.47427186 |
95 | Gap junction_Homo sapiens_hsa04540 | 0.46881393 |
96 | * Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.45286791 |
97 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.45238363 |
98 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.45183626 |
99 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.44693328 |
100 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.42112284 |
101 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.42092583 |
102 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.41626292 |
103 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.41095460 |
104 | Galactose metabolism_Homo sapiens_hsa00052 | 0.40434915 |
105 | Proteasome_Homo sapiens_hsa03050 | 0.38708756 |
106 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.38666409 |
107 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.35476513 |
108 | * Tyrosine metabolism_Homo sapiens_hsa00350 | 0.35063095 |
109 | Tight junction_Homo sapiens_hsa04530 | 0.34899692 |
110 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.34650729 |
111 | Circadian rhythm_Homo sapiens_hsa04710 | 0.33362455 |
112 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.33324604 |
113 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.33173037 |
114 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.32848271 |
115 | * Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.31084172 |
116 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.30454942 |
117 | * Metabolic pathways_Homo sapiens_hsa01100 | 0.30135102 |
118 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.29549560 |
119 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.29156232 |
120 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.28168100 |